Sensex Trades Over 200 Points Higher; Dow Futures Down By 32 Points

Share markets in India are presently trading on a strong note.

The BSE Sensex is trading up by 226 points, up 0.5% at 46,489 levels.

Meanwhile, the NSE Nifty is trading up by 86 points.

Divi's Laboratories and Mahindra & Mahindra are among the top gainers today. Tech Mahindra and Eicher Motors are among the top losers today.

The BSE Mid Cap index is trading up by 0.7%

The BSE Small Cap index is trading up by 1%.

On the sectoral front, barring the banking sector, all sectors are trading in green with stocks from the real estate sector witnessing most of the buying interest.

US stock futures are mixed today.

Nasdaq Futures are trading up by 18 points (up 0.1%) while Dow Futures are trading down by 32 points (down 0.1%).

The rupee is trading at 73.55 against the US$.

Gold prices are trading up 0.4% at Rs 49,635 per 10 grams.

In global markets, gold prices were muted today as a rally in global equity markets took some shine off the yellow metal.

Following an overnight rally in global markets, gold prices edged higher in India. Hopes of the rollout of more US stimulus have supported the recent bounce in gold and silver. On MCX, February gold futures gained 0.3% to Rs 49,571. In the previous session, gold had jumped Rs 530 or 1.1% per 10 grams.

Among the buzzing stocks, today is Biocon Biologics.

Biocon Biologics, a subsidiary of Biocon, signed a Memorandum of Understanding (MoU) with the Christian Social Services Commission (CSSC), a faith-based organization active in Africa, to provide affordable access to quality insulin in the region.

The company is helping unlock universal access to quality insulins in low-and middle-income countries (LMICs) by making recombinant human insulin (rh-insulin) available for less than 10 U.S. cents per day as a part of its 'Mission 10 cents' program.

It is working with local partners to help strengthen overall healthcare capacity with the aim of supporting all people with diabetes in low-to-middle income countries, where diabetes prevalence has been rising more rapidly than in high-income countries.

1 2 3
View single page >> |

Disclosure: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research ...

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.


Leave a comment to automatically be entered into our contest to win a free Echo Show.